Buscar
Danaher Corp
DHRAñadir a la lista de seguimiento
174.648USD
-26.462-13.16%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
123.60BCap. mercado
33.63P/E TTM
Más Datos de Danaher Corp Compañía
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Información de Danaher Corp
Símbolo de cotizaciónDHR
Nombre de la empresaDanaher Corp
Fecha de salida a bolsaJan 16, 2106
Director ejecutivoBlair (Rainer M)
Número de empleados61000
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 16
Dirección2200 Pennsylvania Ave NW Ste 800W
CiudadWASHINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal20037-1701
Teléfono12028280850
Sitio Webhttps://www.danaher.com/
Símbolo de cotizaciónDHR
Fecha de salida a bolsaJan 16, 2106
Director ejecutivoBlair (Rainer M)
Ejecutivos de Danaher Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
+0.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.00M
-2.71%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
87.56K
+2.99%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
19.23K
+11.01%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-29.35%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
9.53K
+34.79%
Mr. Greg Milosevich
Mr. Greg Milosevich
Executive Vice President
Executive Vice President
9.06K
+45.84%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
+0.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.00M
-2.71%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
87.56K
+2.99%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Danaher Corp?
Los cinco principales accionistas de Danaher Corp son: Mr. Steven M. Rales
¿Cuántas instituciones poseen acciones de Danaher Corp (DHR)?
A fecha de 2026Q1, 3953 instituciones poseen acciones de Danaher Corp, con un valor de mercado combinado de aproximadamente 594.48M, lo que representa el 83.99% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -3972448.00.